|Other Names||Zinc finger protein 622, Zinc finger-like protein 9, ZNF622, ZPR9|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP1952a was selected from the N-term region of human ZNF622. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||May behave as an activator of the bound transcription factor, MYBL2, and be involved in embryonic development.|
|Cellular Location||Cytoplasm. Nucleus|
|Tissue Location||Expressed in lung, kidney, spleen, liver and brain with lowest expression in kidney.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
ZNF622 interacts with murine Melk and with itself when expressed in 293T cells. ZNF622 was phosphorylated by Melk both in vitro and in vivo. When expressed alone, ZNF622 exhibited cytosolic and nuclear localization; however, coexpression of ZNF622 with Melk resulted in nuclear localization of ZNF622. ZNF622 also interacts with the transcription factor BMYB in a yeast 2-hybrid assay and coimmunoprecipitated with BMYB when expressed in 293T cells. ZNF622 enhancs the transcriptional activity of BMYB on a reporter plasmid in a dose-dependent manner, and coexpression of ZNF622 and BMYB in 293T cells caused accumulation of both proteins in the nucleus. Constitutive expression of ZNF622 in retinoic acid-treated neuroblastoma cells or 293T cells induced apoptosis, but coexpression of ZNF622 with BMYB inhibited this apoptosis.
Seong, H.A., et al., J. Biol. Chem. 278(11):9655-9662 (2003).Seong, H.A., et al., Biochem. J. 361 (Pt 3), 597-604 (2002).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.